BESREMi (ropeginterferon alfa-2b njft), the first new FDA-approved treatment for essential thrombocythemia in nearly three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results